Higher fasting glucose concentrations are pointing towards a primary defect in hepatic insulin sensitivity [as fasting glucose is mostly regulated by the liver (21)] in GDM patients with overweight or obesity and may be an underlying reason why basal insulin [which suppresses hepatic gluconeogenesis (22)] was more often used in those patients in our study. The gene discussed is INS; the disease is obesity disorder.